FibroGen (FGEN) News Today $0.29 +0.01 (+3.13%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.28 -0.01 (-2.20%) As of 04/17/2025 05:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period William Blair Keeps Their Hold Rating on FibroGen (FGEN)April 2, 2025 | markets.businessinsider.comFibroGen to Participate in the 24th Annual Needham Virtual Healthcare ConferenceApril 2, 2025 | globenewswire.comFibroGen extends merger option deadline with FortisMarch 30, 2025 | investing.comFibroGen announces publication of results from Phase 1 study of FG-3246March 29, 2025 | markets.businessinsider.comFibroGen Down on Peer-Review PublicationMarch 28, 2025 | baystreet.caInsider Buying: FibroGen, Inc. (NASDAQ:FGEN) CEO Purchases 145,000 Shares of StockMarch 26, 2025 | insidertrades.comFibroGen, Inc. (NASDAQ:FGEN) Director Buys $87,500.00 in StockMarch 25, 2025 | insidertrades.comFibroGen, Inc. (NASDAQ:FGEN) Q4 2024 Earnings Call TranscriptMarch 19, 2025 | msn.comFibroGen options imply 18.1% move in share price post-earningsMarch 18, 2025 | markets.businessinsider.comFibroGen, Inc.: FibroGen Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 18, 2025 | finanznachrichten.deFibroGen reports Q4 EPS 18c, consensus (20c)March 18, 2025 | markets.businessinsider.comFibroGen (FGEN) Gets a Hold from William BlairMarch 18, 2025 | markets.businessinsider.comFibroGen, Inc. (FGEN) Q4 2024 Earnings Call TranscriptMarch 17, 2025 | seekingalpha.comFibroGen Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 17, 2025 | globenewswire.comFibroGen to Report Fourth Quarter and Full Year 2024 Financial ResultsMarch 3, 2025 | globenewswire.comFibroGen (FGEN) Expected to Announce Quarterly Earnings on MondayFibroGen (NASDAQ:FGEN) will be releasing earnings before the market opens on Monday, February 24.February 22, 2025 | marketbeat.comFibroGen (NASDAQ:FGEN) Receives Buy Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $10.00 target price on shares of FibroGen in a research note on Thursday.February 21, 2025 | marketbeat.comStockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN)StockNews.com began coverage on shares of FibroGen in a research report on Friday. They issued a "hold" rating for the company.February 21, 2025 | marketbeat.comFibroGen to sell China business, extend cash runway to focus on cancer drugsFebruary 21, 2025 | bizjournals.comFibroGen stock soars on China unit saleFebruary 20, 2025 | in.investing.comThis Small Cap Soared Following Subsidiary Sale Announcement Worth $160MFebruary 20, 2025 | msn.comFibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 MillionFebruary 20, 2025 | finance.yahoo.comFibroGen China sale ‘shrewd strategic transaction,’ says H.C. WainwrightFebruary 20, 2025 | markets.businessinsider.comFibroGen sells China unit to AstraZeneca in deal worth $160 millionFebruary 20, 2025 | reuters.comFibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 MillionFebruary 20, 2025 | globenewswire.comFibroGen, Inc. (NASDAQ:FGEN) Short Interest Down 5.2% in JanuaryFibroGen, Inc. (NASDAQ:FGEN - Get Free Report) was the recipient of a significant drop in short interest during the month of January. As of January 31st, there was short interest totalling 2,910,000 shares, a drop of 5.2% from the January 15th total of 3,070,000 shares. Based on an average daily volume of 1,250,000 shares, the days-to-cover ratio is currently 2.3 days.February 18, 2025 | marketbeat.comSeveral Insiders Invested In FibroGen Flagging Positive NewsFebruary 4, 2025 | finance.yahoo.comFibroGen (NASDAQ:FGEN) Shares Pass Above 50 Day Moving Average - Here's What HappenedFibroGen (NASDAQ:FGEN) Stock Price Passes Above Fifty Day Moving Average - What's Next?January 21, 2025 | marketbeat.comPerspective Therapeutics appoints Graham as CFOJanuary 7, 2025 | markets.businessinsider.comFibroGen (NASDAQ:FGEN) Coverage Initiated by Analysts at StockNews.comStockNews.com began coverage on FibroGen in a research note on Wednesday. They set a "hold" rating for the company.January 1, 2025 | marketbeat.comFibroGen initiated with a Buy at H.C. WainwrightDecember 17, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: FibroGen (FGEN) and Johnson & Johnson (JNJ)December 17, 2024 | markets.businessinsider.comFibroGen, Inc.: FibroGen Appoints David DeLucia as Chief Financial OfficerDecember 16, 2024 | finanznachrichten.deFibroGen Appoints David DeLucia as Chief Financial OfficerDecember 16, 2024 | globenewswire.comFibroGen (NASDAQ:FGEN) Stock, Option ChainNovember 15, 2024 | benzinga.comFibroGen Reports Strong Q3 Growth and Future PlansNovember 13, 2024 | markets.businessinsider.comFibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost ReductionsNovember 13, 2024 | finance.yahoo.comFibroGen, Inc. (FGEN) Q3 2024 Earnings Conference Call TranscriptNovember 12, 2024 | seekingalpha.comFibroGen Reports Third Quarter 2024 Financial ResultsNovember 12, 2024 | globenewswire.comFibroGen to Report Third Quarter 2024 Financial ResultsNovember 4, 2024 | globenewswire.comDisc Medicine appoints Kaushik as Chief Technical OfficerOctober 23, 2024 | markets.businessinsider.comFibroGen Inc (FGEN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ShiftsOctober 9, 2024 | finance.yahoo.comFibroGen to exit Mission Bay lease earlyOctober 4, 2024 | bizjournals.comFibroGen announces executive departures amid cost cutsSeptember 11, 2024 | uk.investing.comFGEN Sep 2024 2.500 callSeptember 8, 2024 | ca.finance.yahoo.comFibroGen to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | markets.businessinsider.comFibroGen, Inc. (NASDAQ:FGEN) Reported Earnings Last Week And Analysts Are Already Upgrading Their EstimatesAugust 9, 2024 | finance.yahoo.comFibroGen Inc.: Sell Rating Maintained Amid Uncertainties and Limited Upside PotentialAugust 8, 2024 | markets.businessinsider.comSan Francisco biotech company FibroGen guts staff after failed cancer trialsAugust 7, 2024 | msn.comFibroGen Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 6, 2024 | markets.businessinsider.com Get FibroGen News Delivered to You Automatically Sign up to receive the latest news and ratings for FGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address FGEN Media Mentions By Week FGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FGEN News Sentiment▼0.000.58▲Average Medical News Sentiment FGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FGEN Articles This Week▼01▲FGEN Articles Average Week Get FibroGen News Delivered to You Automatically Sign up to receive the latest news and ratings for FGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Nkarta News Today Korro Bio News Today Larimar Therapeutics News Today ADC Therapeutics News Today Theratechnologies News Today Compugen News Today Seres Therapeutics News Today Kodiak Sciences News Today Coherus BioSciences News Today FitLife Brands News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FGEN) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FGEN Stock Free FGEN Stock Alerts